Wilms’ tumor is a malignant renal cancer that arises within the pediatric
urinary system. This study intended to investigate how a novel long non-coding
RNA LINC01339 functions in the pathogenesis of Wilms’ tumor. An elevated
miR-135b-3p expression as well as reduced levels of LINC01339 and ADH1C were
observed in Wilms’ tumor. LINC01339 mediated ADH1C expression by
directly binding to miR-135b-3p. The enforced LINC01339 or ADH1C markedly
hindered cell growth and migration in Wilms’ tumor. The LINC01339
overexpression also repressed the growth of Wilms’ tumors in vivo,
whereas miR-135b-3p overexpression exerted the opposite effects on
Wilms’ tumor cells in vitro. Additionally, upregulating miR-135b-3p
reversed LINC01339’s effects on the cellular processes of Wilms’
tumor cells, whereas ADH1C overexpression offset the cancer-promoting influence
of miR-135b-3p upregulation on Wilms’ tumor progression. Therefore,
LINC01339 prevents Wilms’ tumor progression by modulating the
miR-135b-3p/ADH1C axis. Our findings substantiate that the
LINC01339/miR-135 b-3p/ADH1C regulatory axis has potential to be
a target for the treatment of Wilms’ tumor.